|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
90,000,000 |
Market
Cap: |
1.70(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.88 - $18.88 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-10-03 |
4 |
AS |
$30.99 |
$93,415 |
D/D |
(3,000) |
0 |
|
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-10-03 |
4 |
OE |
$1.65 |
$4,950 |
D/D |
3,000 |
3,000 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-10-03 |
4 |
AS |
$30.95 |
$254,811 |
D/D |
(8,181) |
114,768 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-10-03 |
4 |
OE |
$1.27 |
$10,349 |
D/D |
8,181 |
122,949 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-10-03 |
4 |
AS |
$31.00 |
$313,152 |
D/D |
(10,000) |
242,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-10-03 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-09-01 |
4 |
AS |
$32.49 |
$324,949 |
D/D |
(10,000) |
242,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-09-01 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-09-01 |
4 |
AS |
$32.48 |
$324,820 |
D/D |
(10,000) |
114,768 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-09-01 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
|
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-09-01 |
4 |
AS |
$32.47 |
$97,483 |
D/D |
(3,000) |
0 |
|
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-09-01 |
4 |
OE |
$1.65 |
$4,950 |
D/D |
3,000 |
3,000 |
|
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-08-15 |
4 |
AS |
$31.17 |
$93,512 |
D/D |
(3,000) |
0 |
|
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2016-08-15 |
4 |
OE |
$1.65 |
$4,950 |
D/D |
3,000 |
3,000 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-08-01 |
4 |
AS |
$30.65 |
$311,513 |
D/D |
(10,000) |
114,768 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-08-01 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-08-01 |
4 |
AS |
$30.88 |
$198,464 |
D/D |
(6,426) |
242,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-08-01 |
4 |
S |
$31.75 |
$113,484 |
D/D |
(3,574) |
242,232 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-08-01 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-07-27 |
4 |
AS |
$30.15 |
$277,023 |
D/D |
(9,187) |
242,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-07-27 |
4 |
OE |
$1.65 |
$15,159 |
D/D |
9,187 |
251,387 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-07-26 |
4 |
AS |
$30.00 |
$24,392 |
D/D |
(813) |
242,200 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2016-07-26 |
4 |
OE |
$1.65 |
$1,341 |
D/D |
813 |
243,013 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-07-25 |
4 |
AS |
$28.08 |
$280,805 |
D/D |
(10,000) |
114,768 |
|
- |
|
Schatzman Randall C |
President and CEO |
|
2016-07-25 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
|
- |
|
296 Records found
|
|
Page 5 of 12 |
|
|